Klivira
Request demo

Navigating Anthem (Elevance Health) Yervoy Prior Authorization

For clinics and health systems managing oncology patients, efficient Anthem (Elevance Health) Yervoy prior authorization is crucial for timely access to this immune checkpoint inhibitor.

Yervoy (ipilimumab) is a high-volume prior authorization target across commercial, Medicare Advantage, and Medicaid managed care plans. Understanding Anthem's specific requirements, submission channels, and policy frameworks is essential for revenue cycle teams and prior authorization coordinators to minimize delays and denials.

Yervoy Prior Authorization Submission Channels for Anthem Plans

Yervoy, as a specialty injectable often administered under the medical benefit, typically routes through Anthem's standard medical prior authorization channels. This primarily includes the Availity Essentials multi-payer provider workspace for initial submission, benefit lookup, and document uploads. X12 278 transactions are also supported for electronic submission via clearinghouses.

Key Submission Pathways for Yervoy PA with Anthem

  • Medical PA via Availity Essentials for medical benefit Yervoy infusions and related services.
  • X12 278 transactions submitted through clearinghouses for medical benefit authorizations.
  • CarelonRx's provider PA system for pharmacy benefit Yervoy, or through CoverMyMeds / Surescripts ePA for prescriber-initiated workflows (if applicable to specific plan/benefit design).
  • Direct communication with Anthem operating companies for specific state-plan requirements or complex cases.

Anthem Medical Policy and Clinical Criteria for Yervoy

Anthem operating companies publish medical policies and clinical utilization management guidelines via provider sites accessible through Availity. For oncology drugs like Yervoy, these policies frequently reference criteria from the NCCN Compendium. It is critical to consult the specific state-licensed Anthem plan's medical policy index, noting any state-specific Medicaid or Medicare Advantage variants, and the policy's effective date.

Electronic Prior Authorization (ePA) Posture for Elevance Health

Elevance Health, through its Anthem operating companies, has engaged in Da Vinci Project initiatives to advance electronic prior authorization (ePA) using SMART on FHIR standards. While specific production conformance for Da Vinci PAS, CRD, and DTR requires verification, Anthem supports X12 278 for medical benefit PA. For pharmacy benefit, CoverMyMeds and Surescripts ePA pathways are available via CarelonRx.

Common Denial Patterns and Appeal Pathways for Yervoy with Anthem

Denials for Yervoy prior authorizations from Anthem plans often stem from insufficient documentation, medical necessity criteria not met (e.g., non-adherence to NCCN guidelines), or step therapy requirements not fulfilled. Site-of-service mismatch can also be a factor given Anthem's active site-of-care policies. Appeals for standard medical PA follow the Anthem operating-company appeals process documented in provider manuals, with peer-to-peer reviews available.

Turnaround Times and Regulatory Compliance

Anthem-licensed plans' commercial PA timeframes for Yervoy are governed by state insurance regulations, which vary materially across states. For Medicare Advantage, Medicaid managed-care (under Anthem Medicaid plans and Wellpoint), and QHP-on-FFM lines, Anthem is an impacted payer under CMS-0057-F, subject to 72-hour standard and 24-hour expedited PA decision timeframes on the phased compliance timeline. Providers should verify current payer-published service-level targets via the provider portal.

Frequently asked questions

Which Anthem entity handles Yervoy prior authorizations?

Yervoy prior authorizations are typically handled by the specific state-licensed Anthem operating company (e.g., Anthem Blue Cross Blue Shield). As a specialty injectable usually under the medical benefit, submissions primarily route through Availity Essentials, which is Anthem's primary multi-payer provider workspace.

Where can I find Anthem's medical policy for Yervoy?

Anthem medical policies and clinical guidelines for Yervoy are published on the respective state-licensed Anthem plan's provider website, often accessible via Availity. These policies frequently reference criteria from the NCCN Compendium for oncology indications. Always verify the specific policy number, plan-state context, and effective date.

What are common reasons for Yervoy PA denials from Anthem?

Common reasons for Yervoy PA denials from Anthem include insufficient documentation, failure to meet medical necessity criteria (often aligned with NCCN guidelines), non-completion of step therapy requirements, or site-of-service mismatches. Denials are returned via X12 277/835 transactions and Availity status updates.

Does Anthem support electronic prior authorization for Yervoy?

Yes, Anthem (through Elevance Health) supports X12 278 transactions for medical benefit prior authorizations, which would apply to Yervoy. While Elevance Health participates in Da Vinci Project initiatives, specific production conformance status requires verification. For pharmacy benefit Yervoy (if applicable), ePA is available via CoverMyMeds and Surescripts through CarelonRx.

What is the appeal process for a denied Yervoy PA with Anthem?

For denied Yervoy prior authorizations, appeals route through the standard Anthem operating-company appeals process as documented in their provider manuals. This typically includes options for reconsideration and peer-to-peer reviews. State-plan variations, especially for Medicaid lines, should be considered.

Related coverage

Other yervoy prior authorization by payer

Other yervoy prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo